News

Strategy Stock: $2.5 Billion Raise Fuels Bitcoin Buying Spree
Strategy, formerly known as MicroStrategy, has successfully completed a massive capital raise, securing $2.5 billion through preferred stock issuance - five times the originally planned $500 million.
Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its Second Quarter 2025 Financial Results
Lassonde Industries Inc. (TSX: LAS.A) ("Lassonde" or the "Corporation") is pleased to announce that it will host a conference call to discuss its financial results for the second quarter of 2025 on ...
HCA Healthcare Stock: Strong Q2 Drives Outlook Upgrade
HCA Healthcare has delivered impressive second-quarter results that exceeded analyst expectations, with revenue climbing 6.4% to $18.61 billion, surpassing the projected $18.50 billion. The company's ...
Diana Shipping Inc. Announces Time Charter Contract For m/v DSI Phoenix With Cargill Ocean Transportation
Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate ...
CSX Stock: Railroad Merger Wave Fuels Acquisition Speculation
CSX Corporation has become a focal point of merger speculation as industry consolidation gains momentum in the U.S. railroad sector. The company's stock is attracting investor attention following ...
RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call
RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital ...
SIMPPLE Ltd. Fully Regains Compliance with Nasdaq’s Continued Listing Requirements
SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that it has received notice from The ...
Bayer Stock: Cancer Drug Approval Boosts Growth Prospects
The European Commission has granted approval for Bayer's cancer medication Nubeqa to be used in treating metastatic hormone-sensitive prostate cancer, marking a significant milestone for the ...
Tecnoglass Sets Date for Second Quarter 2025 Results
Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, ...
StarragTornos Aktie: Absturz mit Ansage
Die Fusion von Starrag und Tornos entpuppt sich als Fehlstart: Im ersten Halbjahr 2025 stürzte die StarragTornos Group tief in die roten Zahlen. Ein Nettoverlust von 9,1 Millionen Franken markiert ...
Global Business Travel Group: Licht und Schatten
Global Business Travel Group passte seine Erwartungen für 2025 nach unten an: Sollten Anleger sofort verkaufen? Oder lohnt sich doch der Einstieg bei Global Business Travel? Umsatzprognose: 2,38 bis 2 ...
Bank of China: Wird die Notenbank zum Retter?
Die chinesische Notenbank greift mit voller Wucht in den Finanzmarkt ein – und stellt damit die Weichen für die großen Staatsbanken wie die Bank of China. Mit einer milliardenschweren ...